Clinical Trial Update: Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inhaled Interferon gamma-1b for pulmonary Mycobacterium avium complex infection was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Pulmonary Disease

Drugs mentioned

• Interferon-gamma 1b (interferon gamma-1b)

Snippet

Sponsor: InterMune | Conditions: Lung Infection | Phase 2 | Status: TERMINATED